Novelty in science should not come at the cost of reproducibility
- PMID: 31250544
- DOI: 10.1111/febs.14965
Novelty in science should not come at the cost of reproducibility
Abstract
The pressures of a scientific career can end up incentivising an all-or-nothing approach to cross the finish line first. While competition can be healthy and drives innovation, the current system fails to encourage scientists to work reproducibility. This sometimes leaves those individuals who come second to correct mistakes in published research without being rewarded. Instead, we need a culture that rewards reproducibility and holds it as important as the novelty of the result. Here, I draw on my own journey in the oestrogen receptor research field to highlight this and suggest ways for the 'first past the post' culture to be challenged.
© 2019 Federation of European Biochemical Societies.
Similar articles
-
Scientific impact and the quest for visibility.FEBS J. 2019 Oct;286(20):3968-3974. doi: 10.1111/febs.15043. Epub 2019 Aug 29. FEBS J. 2019. PMID: 31468701
-
How should novelty be valued in science?Elife. 2017 Jul 25;6:e28699. doi: 10.7554/eLife.28699. Elife. 2017. PMID: 28742499 Free PMC article.
-
Reforming science: structural reforms.Infect Immun. 2012 Mar;80(3):897-901. doi: 10.1128/IAI.06184-11. Epub 2011 Dec 19. Infect Immun. 2012. PMID: 22184420 Free PMC article.
-
n-index: a novel and easily-calculable parameter for comparison of researchers working in different scientific fields.Indian J Dermatol Venereol Leprol. 2010 May-Jun;76(3):229-30. doi: 10.4103/0378-6323.62960. Indian J Dermatol Venereol Leprol. 2010. PMID: 20445291 Review. No abstract available.
-
The Costs of Reproducibility.Neuron. 2019 Jan 2;101(1):11-14. doi: 10.1016/j.neuron.2018.11.030. Neuron. 2019. PMID: 30605654 Review.
References
-
- Shang Y, Hu X, DiRenzo J, Lazar MA & Brown M (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103, 843-852.
-
- Holding AN, Cullen AE & Markowetz F (2018) Genome-wide Estrogen Receptor-α activation is sustained, not cyclical. eLife 7, e40854.
-
- Métivier R, Penot G, Hübner MR, Reid G, Brand H, Koš M & Gannon F (2003) Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115, 751-763.
-
- Holding AN, Giorgi FM, Donnelly A, Cullen AE, Nagarajan S, Selth LA & Markowetz F (2019) VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer. Genome Biol 20, 91.
-
- Guertin MJ, Cullen AE, Markowetz F & Holding AN (2018) Parallel factor ChIP provides essential internal control for quantitative differential ChIP-seq. Nucleic Acids Res 46, e75-e75.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous